These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8562713)

  • 21. Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia.
    Gao B; Kilic E; Baumann CR; Hermann DM; Bassetti CL
    Cerebrovasc Dis; 2008; 26(4):413-9. PubMed ID: 18753748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central anticholinergic syndrome (CAS) in anesthesia and intensive care.
    Schneck HJ; Rupreht J
    Acta Anaesthesiol Belg; 1989; 40(3):219-28. PubMed ID: 2683549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand.
    Wu H; Zink N; Carter LP; Mehta AK; Hernandez RJ; Ticku MK; Lamb R; France CP; Coop A
    J Pharmacol Exp Ther; 2003 May; 305(2):675-9. PubMed ID: 12606613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility of D-glucuronate to enhance gamma-hydroxybutyric acid metabolism during gamma-hydroxybutyric acid toxicity: pharmacokinetic and pharmacodynamic studies.
    Bhattacharya I; Boje KM
    Biopharm Drug Dispos; 2007 Jan; 28(1):1-11. PubMed ID: 17061294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features and management of gamma-hydroxybutyrate (GHB) withdrawal: a review.
    McDonough M; Kennedy N; Glasper A; Bearn J
    Drug Alcohol Depend; 2004 Jul; 75(1):3-9. PubMed ID: 15225884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit.
    Barr J; Donner A
    Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cerebral protection].
    Cattaneo AD
    Minerva Anestesiol; 1993 Sep; 59(9):403-17. PubMed ID: 8278062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of cerebral ischemia].
    Heiss WD
    Z Kardiol; 1987; 76 Suppl 4():87-98. PubMed ID: 3327270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Schirman S; Wagner A; Poustka F; Wöckel L
    Z Kinder Jugendpsychiatr Psychother; 2009 Sep; 37(5):413-20. PubMed ID: 19739059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
    Elsing C; Stremmel W; Grenda U; Herrmann T
    Am J Drug Alcohol Abuse; 2009; 35(3):189-92. PubMed ID: 19462303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gamma-hydroxybutyrate--an endogenous substance and an intoxicant].
    Hovda KE; Liberg JP; Nordby G; Jacobsen D
    Tidsskr Nor Laegeforen; 1998 Nov; 118(28):4390-3. PubMed ID: 9889613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in neuronal transport but not blood-brain barrier transport are observed during gamma-hydroxybutyrate (GHB) sedative/hypnotic tolerance.
    Bhattacharya I; Raybon JJ; Boje KM
    Pharm Res; 2006 Sep; 23(9):2067-77. PubMed ID: 16952000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gamma-hydroxybutyrate withdrawal syndrome.
    Tarabar AF; Nelson LS
    Toxicol Rev; 2004; 23(1):45-9. PubMed ID: 15298492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice.
    Cook CD; Aceto MD; Coop A; Beardsley PM
    Psychopharmacology (Berl); 2002 Feb; 160(1):99-106. PubMed ID: 11862379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines.
    Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL
    Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Properties allowing the attribution to gamma-hydroxybutyrate the quality of neurotransmitter in the central nervous system].
    Maitre M; Mandel P
    C R Acad Sci III; 1984; 298(12):341-5. PubMed ID: 6145513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine.
    Raybon JJ; Boje KM
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1252-60. PubMed ID: 17138862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tale of novel intoxication: a review of the effects of gamma-hydroxybutyric acid with recommendations for management.
    Li J; Stokes SA; Woeckener A
    Ann Emerg Med; 1998 Jun; 31(6):729-36. PubMed ID: 9624313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ethanol and acetaldehyde on gamma-hydroxybutyric acid in rat brain and liver.
    Poldrugo F; Snead OC
    Subst Alcohol Actions Misuse; 1984; 5(5):263-71. PubMed ID: 6543478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.